Zobrazeno 1 - 10 of 256 pro vyhledávání: '"Stephan, Miehlke"'
1
Therapie der eosinophilen Ösophagitis - Fortschritte und Perspektiven
Autor: Ulrike von Arnim, Ahmed Madisch, Stephan Miehlke, Joachim Labenz, Christoph Schlag
Publikováno v: Laryngo-Rhino-Otologie. 102:339-348
ZusammenfassungIn jüngster Zeit wurden in der Therapie der eosinophilen Ösophagitis (EoE) und insbesondere im Bereich der topischen Corticosteroide erhebliche Fortschritte erreicht. Neue EoE-spezifische Darreichungsformen wurden entwickelt und habe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa06f1e5a45bd169cd7baf1670656f9
https://doi.org/10.1055/a-1861-7152
Zobrazit plný text záznamu
2
Akademický článek
Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
Autor: Stephan Miehlke, Alfredo J. Lucendo, Alex Straumann, Albert Jan Bredenoord, Stephen Attwood
Publikováno v: Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder of the esophagus characterized by symptoms of esophageal dysfunction and eosinophil-predominant inflammation. The incidence of EoE has increased substantially over the past two decades
Externí odkaz: https://doaj.org/article/087b911a9ef7455dbc73c5ef4be62db7
Zobrazit plný text záznamu
3
Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis
Autor: Stephan, Miehlke, Christoph, Schlag, Alfredo J, Lucendo, Luc, Biedermann, Cecilio Santander, Vaquero, Christoph, Schmoecker, Jamal, Hayat, Petr, Hruz, Constanza, Ciriza de Los Rios, Albert Jan, Bredenoord, Michael, Vieth, Alain, Schoepfer, Stephen, Attwood, Ralph, Mueller, Sarah, Burrack, Roland, Greinwald, Alex, Straumann
Publikováno v: United European gastroenterology journal, 10(3), 330-343. SAGE Publications Inc.
Background: A novel budesonide orodispersible tablet (BOT) has been proven effective in adult patients with active eosinophilic oesophagitis (EoE) in a 6-week placebo-controlled trial (EOS-1). Aims: To report the efficacy of an open-label induction t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42845867601fac47d363759ca4ad191d
https://doi.org/10.1002/ueg2.12220
Zobrazit plný text záznamu
6
Menthacarin, a proprietary peppermint oil and caraway oil combination, improves multiple complaints in patients with functional gastrointestinal disorders – a systematic review and meta-analysis
Autor: Ahmed Madisch, Thomas Frieling, Andrea Zimmermann, Margrit Hollenz, Joachim Labenz, Berenike Stracke, Stephan Miehlke
Publikováno v: Digestive Diseases.
Introduction: This systematic review summarizes published data on Menthacarin, the proprietary combination of peppermint oil and caraway oil, in the treatment of functional gastrointestinal disorders. Efficacy was assessed by meta-analysis of placebo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5bee177989cd508ac64a1cbc5566ec81
https://doi.org/10.1159/000528553
Zobrazit plný text záznamu
7
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations
Autor: Ulrike von Arnim, Luc Biedermann, Seema S. Aceves, Peter A. Bonis, Margaret H. Collins, Evan S. Dellon, Glenn T. Furuta, Nirmala Gonsalves, Sandeep Gupta, Ikuo Hirano, Alfredo J. Lucendo, Stephan Miehlke, Salvatore Oliva, Christoph Schlag, Alain Schoepfer, Alex Straumann, Michael Vieth, Albert J. Bredenoord
Publikováno v: Clinical gastroenterology and hepatology. W.B. Saunders Ltd
Background & Aims: There are no studies or recommendations on optimal monitoring strategies for patients with eosinophilic esophagitis (EoE). Our objective was to develop guidance on how to monitor patients with EoE in routine clinical practice, on t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6ea084257d30387ebaefb8ba5366e2
https://doi.org/10.1016/j.cgh.2022.12.018
Zobrazit plný text záznamu
8
Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo‐controlled multicentre trial
Autor: Andreas Münch, Roland Greinwald, Jordi Guardiola, Ralf Mohrbacher, Daniela E. Aust, Lars Kristian Munck, Ferenc Nagy, Ahmed Madisch, Johan Bohr, Gerd Bouma, Blanca Belloc, Stephan Miehlke, Emese Mihály, Juozas Kupcinskas, Chunliang Shi
Publikováno v: United European Gastroenterology Journal
Münch, A, Mihaly, E, Nagy, F, Madisch, A, Kupčinskas, J, Miehlke, S, Bohr, J, Bouma, G, Guardiola, J, Belloc, B, Shi, C, Aust, D, Mohrbacher, R, Greinwald, R & Munck, L K 2021, ' Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial ', United European Gastroenterology Journal, vol. 9, no. 7, pp. 837-847 . https://doi.org/10.1002/ueg2.12131
Münch, A, Mihaly, E, Nagy, F, Madisch, A, Kupčinskas, J, Miehlke, S, Bohr, J, Bouma, G, Guardiola, J, Belloc, B, Shi, C, Aust, D, Mohrbacher, R, Greinwald, R & Munck, L K 2021, ' Budesonide as induction therapy for incomplete microscopic colitis : A randomised, placebo-controlled multicentre trial ', United European Gastroenterology Journal, vol. 9, no. 7, pp. 837-847 . https://doi.org/10.1002/ueg2.12131
Dipòsit Digital de la UB
Universidad de Barcelona
United European Gastroenterology Journal, 9(7), 837-847. SAGE Publications Inc.
Background and aims: Incomplete microscopic colitis (MCi) is a subtype of microscopic colitis (MC). Budesonide is recommended as a first-line treatment for MC. However, randomised trials on efficacy of treatment in MCi are missing. We therefore perfo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e2659d961f7db571839807342e224a9
http://europepmc.org/articles/PMC8435258
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje